Skip to main content
SpringerLink
Log in

Factor XIII gene V34L mutation in the Lebanese population: Another unique feature in this community?

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

We studied the distribution of the Factor XIII gene V34L polymorphism in a sample of healthy Lebanese individuals to assess its prevalence and compare it with other populations. Factor XIII genotypes were determined using the Cardiovascular Disease (CVD) StripAssay (ViennaLab, Austria), which is based on a Polymerase Chain Reaction-Reverse hybridization technique. DNA from 205 unrelated healthy donors from our HLA database was used. The prevalence of Wild type, heterozygous, and homozygous genotypes was found to be 74.2%, 22.4%, and 3.4% respectively. The sampled Lebanese population showed that the prevalence of V34L carriers (25.8%) was lower than Caucasians in general (44.3%) and, interestingly, with a low allele frequency of 0.14 similar to that in Blacks and South Asians. This first report from Lebanon sheds light on an additional unique genetic feature of this population and will prospectively serve as a baseline statistical data for future investigations of the prevalence of Factor XIII V34L mutation in association with various clinical entities notably cardiovascular diseases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Webb GC, Coggan M, Ichinose A et al (1989) Localization of the coagulation factor XIII B subunit gene (F13B) to chromosome bands 1q31–32.1 and restriction fragment length polymorphism at the locus. Hum Genet 81:157–160

    Article  PubMed  CAS  Google Scholar 

  2. Board PG, Webb GC, McKee J et al (1988) Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24–p25. Cytogenet Cell Genet 48:25–27

    Article  PubMed  CAS  Google Scholar 

  3. Wells P, Anderson J, Scarvelis D et al (2006) Factor XIII Val34Leu variant is protective against venous thromboembolism: a huge review and meta-analysis. Am J Epidemiol 164:101–109

    Article  PubMed  Google Scholar 

  4. Ariens R, Lai TS, Weisel J et al (2002) Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood 100:743–754

    Article  PubMed  CAS  Google Scholar 

  5. Catto A, Kohler H, Coore J et al (1999) Association of a common polymorphism in the factor XIII gene with venous thrombosis. Blood 93: 906–908

    PubMed  CAS  Google Scholar 

  6. Mikkola H, Syrjala M, Rasi V et al (1994) Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84:517–525

    PubMed  CAS  Google Scholar 

  7. Kohler HP, Whitaker P, Grant PJ (1998) A common coding polymorphism in the FXIII A-subunit gene (FXIIIVal34Leu) affects cross-linking activity. Thromb Haemost 80:704

    PubMed  CAS  Google Scholar 

  8. Kohler HP, Stickland MH, Ossei-Gerning N et al (1998) Association of a common polymorphism in the factor XIII gene with myocardial infarction. Thromb Haemost 79:8–13

    PubMed  CAS  Google Scholar 

  9. Wartiovaara U, Perola M, Mikkola H et al (1999) Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis 142:295–300

    Article  PubMed  CAS  Google Scholar 

  10. Lim BC, Carter AM, Weisel JW et al (2003) Genetic regulation of fibrin structure and function: complex gene-environment interactions may modulate vascular risk. Lancet 361:1424–1431

    Article  PubMed  CAS  Google Scholar 

  11. Warner D, Mansfield MW, Grant PJ (2001) Coagulation factor XIII and cardiovascular disease in UK Asian patients undergoing coronary angiography. Thromb Haemost 85:408–411

    PubMed  CAS  Google Scholar 

  12. Corral J, Gonzalez-Conejero R, Iniesta JA et al (2000) The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 85:293–27

    PubMed  CAS  Google Scholar 

  13. Endler G, Funk M, Haering D et al (2003) Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease?. Br J Haematol 120:310–314

    Article  PubMed  CAS  Google Scholar 

  14. McCormack LJ, Kain K, Catto AJ et al (1998) Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost 80:523–524

    PubMed  CAS  Google Scholar 

  15. van Hylckama Vlieg A, Komanasin N, Ariens RA et al (2002) FactorXIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis. Br J Haematol 119:169–175

    Article  PubMed  Google Scholar 

  16. Renner W, Koppel H, Hoffman C et al (2000) Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res 99:35–39

    Article  PubMed  CAS  Google Scholar 

  17. Zidane M, de Visser MCH, ten Wolde M et al (2003) Frequency of the TAFI - 438 G/A and factor XIIIA Val34Leu polymorphisms in patients with objectively proven pulmonary embolism. Thromb Haemost 90:439–445

    PubMed  CAS  Google Scholar 

  18. Dowling NF, Austin H, Dilley A et al (2003) The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost 1:80–87

    Article  PubMed  CAS  Google Scholar 

  19. Hoppe B, Tolou F, Dorner T, Kiesewetter H, Salama A (2006) Gene polymorphisms implicated in influencing susceptibility to venous and arterial thromboembolism: frequency distribution in a healthy German population. Thromb Haemost 96:465–470

    PubMed  CAS  Google Scholar 

  20. Balogh I, Szoke G, Karpati L et al (2000) Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood 96:2479–2486

    PubMed  CAS  Google Scholar 

  21. Franco RF, Reitsma PH, Lourenco D et al (1999) Factor XIII Val34Leu is a genetic factor involved in the aetiology of venous thrombosis. Thromb Haemost 81:676–679

    PubMed  CAS  Google Scholar 

  22. Alhenc-Gelas M, Reny JL, Aubry ML et al (2000) The FXIII Val 34 Leu mutation and the risk of venous thrombosis. Thromb Haemost 84:1117–1118

    PubMed  CAS  Google Scholar 

  23. Margaglione M, Bossone A, Brancaccio V et al (2000) Factor XIII Val34Leu polymorphism and risk of deep vein thrombosis. Thromb Haemost 84:1118–1119

    PubMed  CAS  Google Scholar 

  24. Heng CK, Lal S, Saha N, Low PS, Kamboh MI (2004) The impact of factor XIIIa V34L polymorphism on plasma factor XIII activity in the Chinese and Asian Indians from Singapore. Hum Genet 114:186–191

    Article  PubMed  CAS  Google Scholar 

  25. Ariens RA, Philippou H, Nagaswami C et al (2000) The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 96:988–995

    PubMed  CAS  Google Scholar 

  26. Gemmati D, Serino ML, Ongaro A et al (2001) A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol 67:183–188

    Article  PubMed  CAS  Google Scholar 

  27. Reiner AP, Frank MB, Schwartz SM (2002) Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol 116:376–382

    Article  PubMed  CAS  Google Scholar 

  28. Aleksic N, Ahn C, Wang YW et al (2002) Factor XIIIA Val34Leu polymorphism does not predict risk of coronary artery disease: the atherosclerosis risk in communities (ARIC) study. Arterioscler Thromb Vasc Biol 22:348–352

    Article  PubMed  CAS  Google Scholar 

  29. Canavy I, Henry M, Morange PE (2000) Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost 83:212–216

    PubMed  CAS  Google Scholar 

  30. Atherosclerosis, Thrombosis, Vascular Biology Italian Study Group (2003) No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation 107:1117–1122

    Google Scholar 

  31. Catto AJ, Kohler HP, Bannan S et al (1998) Factor XIII gene Val34Leu genotype: a novel association with primary intracerebral haemorrhage. Stroke 29:813

    PubMed  CAS  Google Scholar 

  32. Attie-Castro FA, Zago MA, Lavinha J et al (2000) Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost 84:601–603

    PubMed  CAS  Google Scholar 

  33. Corral J, Iniesta JA, Gonzalez-Conejero R, Villalon M, Vicente V (2001) Polymorphisms of clotting factor modify the risk for primary intracranial hemorrhage. Blood 97:2979–2782

    Article  PubMed  CAS  Google Scholar 

  34. Maurer MC, Trumbo TA, Isetti G, Turner BT Jr (2006) Probing interactions between the coagulants thrombin, Factor XIII, and fibrin(ogen). Arch Biochem Biophys 445:36–45

    Article  PubMed  CAS  Google Scholar 

  35. Trumbo TA, Maurer MC (2000) Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation. J Biol Chem 275:20627–20631

    Article  PubMed  CAS  Google Scholar 

  36. Taher A, Khalil I, Shamseddine A et al (2001) High prevalence of Factor V Leiden mutation among healthy individuals and patients with deep venous thrombosis in Lebanon: is the eastern Mediterranean region the area of origin of this mutation? Thromb Haemost 86:723–724

    PubMed  CAS  Google Scholar 

  37. Zaatari G, Otrock Z, Sabbagh AS, Mahfouz R (2006) Prevalence of factor V R2 (H1299R) polymorphism in the Lebanese population. Pathology 38: 442–444

    Article  PubMed  CAS  Google Scholar 

  38. Mahfouz R, Sabbagh AS, Zahed L et al (2006) Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population. Mol Biol Rep 33:145–149

    Article  PubMed  CAS  Google Scholar 

  39. Sabbagh AS, Otrock ZK, Mahfoud ZR, Zaatari GS, Mahfouz RA (2007) Angiotensin-converting enzyme gene polymorphism and allele frequencies in the lebanese population: prevalence and review of the literature. Mol Biol Rep 34:47–52

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. American University of Beirut Medical Center, Department of Pathology, And Laboratory Of Medicine, P.O. Box 11-0236, Riad El Sol, Beirut, 1107 2020, Lebanon

    Rami A. R. Mahfouz, Amira S. Sabbagh, Dina M. R. Shammaa & Ghazi S. Zaatari

  2. Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon

    Zaher K. Otrock & Ali T. Taher

Authors
  1. Rami A. R. Mahfouz
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Amira S. Sabbagh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dina M. R. Shammaa
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Zaher K. Otrock
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ghazi S. Zaatari
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Ali T. Taher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rami A. R. Mahfouz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mahfouz, R.A.R., Sabbagh, A.S., Shammaa, D.M.R. et al. Factor XIII gene V34L mutation in the Lebanese population: Another unique feature in this community?. Mol Biol Rep 35, 375–378 (2008). https://doi.org/10.1007/s11033-007-9096-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-007-9096-0

Keywords

Search

Navigation